Greg Williams

Position

Senior Associate

Service(s)

Corporate

Related sectors

Healthcare

Area of expertise

Public and private mergers and acquisitions
Equity and debt investments
Joint ventures
Listings
Management buy-outs/buy-ins
Restructurings
General corporate advice

Profile

Greg has acted as lead contact on a number of corporate transactions since he joined Hugh James in 2008. He has been the principal contact on numerous equity and debt investments by Finance Wales following Hugh James's appointment to the Welsh Assembly Government corporate finance panel.

Greg is also head of the dedicated healthcare team of specialist solicitors and has sector experience and understanding of advising and acting on corporate transactions for a number of health care clients.

Corporate cases

Advising Finance Wales on its equity and debt investments
Advising A J Access Platforms on its acquisition of the service access fleet of SGB Services Limited
Advising a group company of Liberty Properties plc on the sale of its interest in apartments2book.com
Advising New Zealand listed Opus International Consultants on share and business acquisitions including a £6 million purchase of the Nottingham based Joynes Pike Group and also advising on its UK reorganisation
Advising REL Acoustics in the sale of its business of manufacturing high quality acoustic amplifiers to an American competitor for £4.8 million
Acting for Punch International (Netherlands listed company) in the multi million pound sale of its UK operation of manufacturing consumer electronics for Sony in Bridgend
Acting on the AIM listing of British Biocell International Plc
Advising P3 Technology (multi national investor body) on the restructure of its £4 million investment in Gamma Projects
Advising on a range of corporate structure documents including joint ventures, partnership agreements, LLP agreements and community interest companies

Healthcare matters

Advising Hafod Care Association on its proposed purchase of a care home
Advising G & E J Morris on the sale of its pharmaceutical businesses to Lloyds Pharmacists
Acting for shareholders of Brecon Pharmaceuticals on the sale of their shares to Amerisource Bergen Corporation for a total consideration of $71 million
Advising a consortium of othodontic practices on their funding and PDS contract negotiations with Cardiff LHB